Tumor-infiltrating lymphocytes and survival in melanoma
Atezolizumab with erlotinib in combination treatment for EGFR mutant NSCLC
Clinical implications of CTCs in prostate cancer – are they the best thing to measure?
Checkpoint blockade in patients with brain metastases
The use of mouse models in melanoma with brain metastases to test new therapies